CITA Biomedical, Inc. (DTOX)

[jmhollen]

Leading Chemical Dependency Recovery Center to Offer CITA Biomedical's Groundbreaking Treatments for Alcohol, Cocaine, and Crack Dependence

San Pedro Hospital's Peninsula Chemical Dependency Recovery Center to Begin Treating Patients in Early October 2002

BEVERLY HILLS, Calif., Oct. 4 /PRNewswire-FirstCall/ -- CITA Biomedical, Inc. (OTC Bulletin Board: DTOX) a growing leader in the treatment of addiction dependency, today announced that it has reached an agreement with Little Company of Mary-San Pedro Hospital (LCM-SPH) in Los Angeles County, California to provide CITA's Detoxification and NeuroAdaptation (DNA) for Addictions family of treatments.

(Photo: http://www.newscom.com/cgi-bin/prnh/19990413/LAPHOTO )

The San Pedro Hospital's Peninsula Recovery Center will start treating patients with DNA for Addictions in early October. The DNA for Addictions treatment family includes DNA for Alcohol, DNA for Alcohol and Cocaine, DNA for Cocaine, and DNA for Crack Cocaine. CITA has patents pending for the family of DNA treatments.

"We are pleased to add the DNA treatments as an option for our patients suffering from substance dependency," said Dr. Crescenzo Pisano, Medical Director of LCM-SPH Peninsula Recovery Center. "The DNA technology now allows us to treat addiction at the source, providing renewed hope for those who were previously unresponsive to former treatment attempts. The combination of CITA's treatments and our recovery services provides our community with the most advanced and effective treatment options available, safely administered by our specially-trained medical professionals."

Addiction is a brain disease/disorder and DNA for Addictions treats addiction at the source. Historically the disease of addiction has been treated through behavioral intervention, but DNA for Addictions treatments provide a solution for treating the physiological and psychological components of this devastating condition. Substance abuse impedes normal neural functioning of the brain and body systems as a whole; resulting in cravings, potentially serious or even life-threatening withdrawal symptoms, and damage to the brain. The CITA DNA treatment reduces or eliminates cravings while correcting and regulating the neural functioning.

By providing successful detoxification and neural adaptation solutions that reduce the time, severity, pain and cost associated with withdrawal, the DNA for Addictions process allows the patient to concentrate on returning to a productive level of functioning in a very short time. DNA for Addictions treatments occur over two to three days, depending on the addiction(s) being treated. The process is performed under medical supervision followed by a continuing care program.

Completion rates for the DNA treatment process far exceed standard detoxification solutions, approaching a 100% completion rate. DNA for Addictions treatments have a relapse rate of less than 25%, in contrast with a relapse rate exceeding 75% for those people treated by other methods.

"By working together, CITA, LCM-SPH, and its highly competent medical staff are able to offer high-quality, safe, and cost-effective substance dependence recovery services," said Joseph Dunn, president and CEO of CITA Biomedical. "CITA's mission is to make the transition from substance dependence to independence as quick, smooth and humane as possible. With DNA for Addictions we've done that. We plan to continue to partner with leading treatment centers in order to make the DNA for Addictions treatment family widely available across the U.S. and Canada."

About CITA Biomedical, Inc.

CITA Biomedical, Inc., headquartered in Beverly Hills, Calif., focuses on the innovative treatment of addiction. The company holds the U.S. patent for its successful UROD (Ultra Rapid Opiate Detoxification) treatment method. UROD is the only clinically tested and effective treatment method to rapidly detoxify individuals addicted to opiate-based drugs, including heroin, within four to six hours with few, if any, withdrawal symptoms. The company has a new family of revolutionary treatments, Detoxification and NeuroAdaptation (DNA) for Addictions. The first treatments from this family treat alcohol, cocaine, crack cocaine, and poly-drug addictions. To date, CITA has grown its business through internal expansion and now seeks compatible, leading, and complementing technologies and acquisitions to enhance its corporate portfolio. CITA Biomedical, Inc. has two operating divisions CITA Americas, Inc., and AltTPro, Inc. For more information, please visit www.citabio.com.

About Little Company of Mary San Pedro Hospital

Little Company of Mary San Pedro Hospital is affiliated with Little Company of Mary Health Services. Little Company of Mary is an integrated, regional health care system serving communities in the South Bay area of Southern California comprised of more than 30 different medical and health care facilities and services, including Little Company Of Mary Hospital-Torrance and Little Company of Mary-San Pedro Hospital.

Little Company of Mary is a member of the Providence Health System. Providence Health System operates 20 acute care hospitals, 9 freestanding long-term care facilities, and 15 low-income and assisted living facilities. Providence Health System extends its mission of caring and commitment across a four-state area -- Alaska, Washington, Oregon, and Southern California. A comprehensive array of services is available to meet the varied needs of communities. These include acute and primary care, outpatient services, transitional care, home and hospice care, substance abuse programs, mental health treatment, comprehensive outreach programs including prevention and wellness, long-term care, and housing.

NOTE: UROD is a registered trademark of CITA Biomedical, Inc.

Contacts: Investor Relations Treatment Information
CITA Biomedical, Inc. Call: 1-888-400-2482
Judy Ryon, 310-550-4971 or
[e-mail] Visit: www.cita1.com

SOURCE CITA Biomedical, Inc.

CONTACT: Judy Ryon of CITA Biomedical, Inc., [phone], or
[e-mail], or Treatment Information, 1-888-400-2482

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19990413/LAPHOTO

AP Archive: http://photoarchive.ap.org

PRN Photo Desk, [phone] or [phone]/

Web site: http://www.cita1.com/

Web site: http://www.citabio.com/